We demonstrate that presence of PTH1R is required in both breast cancer cells and osteoblasts for the inhibitory actions of PTH on bone metastasis, because mice lacking PTH1R in breast cancer cells and mice with impaired PTH1R signaling in osteoblasts both exhibit resistance to the effects of intermittent PTH treatment in reducing bone metastases. This evidence concerns the gene PTH1R and breast carcinoma.